JP2015150250A - Needleless syringe - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a needleless syringe capable of more easily applying injection to an injection target area having a relatively hairy surface.SOLUTION: A needleless syringe 1 comprises: a housing 2 that forms a shell container of the needleless syringe 1; a nozzle part 6 that has an emitting port 6b formed for emitting an objective injection substance; and a first projection member 8 that is provided at the housing 2, has a tip 8a projecting from the emitting port 6b toward an emission direction of the objective injection substance and exposes a contact position to be contacted by the emitting port 6b when a movement of the tip 8a along the surface of an injection target area inclines hair on a surface of the injection target area to the moving direction. The first projection member 8 deforms while maintaining an inclined state of the inclined hair when the emitting port 6b is moved close to the contact position, and then projects the emitting port 6b from the tip 8a of the first projection member 8 toward the emission direction.

Description

  The present invention relates to a needleless syringe that injects a substance to be injected into an injection target region of a living body without using an injection needle.

  In a needleless syringe that performs injection without going through an injection needle, in general, an injection solution is injected from an injection port by applying pressure to an injection solution containing a drug or the like by a pressurized gas or a spring. A needleless syringe is more convenient than a conventional syringe that requires insertion of an injection needle because injection can be performed by operating the injection port through which the injection solution is injected in close contact with the skin. The nature is very high. Here, in order to suppress liquid leakage from between the injection port and the skin at the time of injection of the injection solution and perform more effective and reliable injection, it is important to make the injection port more closely contacted with the skin. is there. Thus, for example, Patent Document 1 discloses a needleless syringe including a setting member that protrudes more in the injection direction than the injection port. According to this needleless syringe, since the posture of the syringe is regulated by the regulating member, the ejection port comes into contact with the skin vertically, so that the ejection port can be more closely attached to the skin. become.

Japanese Patent Laid-Open No. 11-276584

  By the way, when an animal is injected using the needleless syringe disclosed in Patent Document 1 described above, if the animal to be injected has a lot of body hair such as a rabbit, the body hair becomes an obstacle. It becomes difficult to visually check the position where the injection port comes into contact. In addition, when the hair is sandwiched between the setting member or the injection port and the skin, it may be difficult to make the injection port sufficiently adhere to the skin. The same problem may occur even when a needleless syringe that does not include a setting member is used. Here, if the hair that grows at the position where the regulating member and the injection port come into contact with each other is removed in advance by a treatment such as shaving, the injection port can be sufficiently adhered. However, since the labor required for the entire injection action increases, the convenience of the needleless syringe is impaired.

  In view of the above-described problems, an object of the present invention is to provide a needleless syringe capable of performing injection more easily in an injection target region having a relatively large body hair on the surface.

  In order to solve the above-described problem, in the needleless syringe according to the present invention, the position where the injection port contacts is exposed by tilting the hair that grows on the surface of the injection target region, and the injection port corresponds to the position. The protrusion member which can maintain the state where the said position was exposed until it contact | abutted to was provided.

Specifically, the needleless syringe according to the present invention is a needleless syringe that injects the injection target substance into an injection target region of a living body having body hair by ejecting the injection target substance without going through an injection needle. A housing forming an outer shell container of the needleless syringe, a nozzle portion provided in the housing and having an injection port through which the injection target substance is injected, and a tip provided in the housing. A member projecting from the injection port toward the injection direction of the injection target substance, and the body hair growing on the surface is tilted in the movement direction by the movement of the tip along the surface of the injection target region. A first projecting member that exposes a contact position with which the ejection port is abutted, wherein the first projecting member is tilted when the ejection port is brought close to the contact position By deforming while maintaining the tilted state, configured to protrude the injection outlet in said injection direction than the first projecting member.

  The above-mentioned injection target substance contains a component that is expected to be effective inside the injection target region of a living body, and as long as injection from the injection port is possible, the accommodation state in the housing, fluid / powder The physical form of the body is not questioned. That is, the injection target substance is generally a liquid, but may be a gel-like solid as long as fluidity enabling injection is ensured. Furthermore, the injection target substance may be in a powder state. The injection target substance includes a component to be sent into the injection target region, and the component may exist in a state dissolved in the injection target substance, or the component is simply mixed without being dissolved. It may be in the state.

  In the needleless syringe according to the present invention, the injection target substance is injected by being pressurized by a known pressurizing mechanism. As this pressurizing mechanism, various mechanisms can be adopted as long as the injection target substance can be pressurized and injected. For example, those using elastic force from springs, using pressurized gas, using gas pressure generated by combustion of explosives, electric actuators for pressurization (motors, piezo elements, etc.) ) And the like. Moreover, the form which achieves pressurization by a user's manual can also be employ | adopted. These pressurizing mechanisms are preferably housed in the housing of the needleless syringe.

  In the needleless syringe according to the present invention, the housing as the outer shell container is provided with a first projecting member whose tip projects from the ejection port toward the injection direction of the injection target substance. Thereby, when the user first brings the needleless syringe close to the injection target area, the tip of the first projecting member comes into contact with the surface of the injection target area before the injection port comes into contact. In the state where the tip of the first projecting member is in contact with the surface, a part or all of the tip is in contact with the surface while sandwiching the body hair growing on the surface of the injection target region. Is also included. And if the front-end | tip of a 1st protrusion member moves along the said surface in the state which contact | abutted the surface of the injection object area | region, the body hair pressed by the said front-end | tip during movement will be inclined in the moving direction. As a result, the target position for bringing the injection port into contact with the boundary between the region where the body hair is tilted on the surface and the region where the body hair is not tilted and the vicinity thereof (that is, the contact position where the injection port is contacted) ) Is exposed. When the contact position is thus exposed, the tip of the first projecting member is in contact with the surface of the injection target region, or the thickness of the hair that is sandwiched between the tip and the surface. Only considered to be away from the surface. Here, when the ejection port is brought close to the contact position, the first projecting member described above deforms the tilted body hair while maintaining the tilted body hair, so that the ejection port is ejected from its tip. Can project to the side. Therefore, according to the needleless syringe according to the present invention, the injection port can be brought into contact with the contact position while the contact position is exposed by the first projecting member. Even when a relatively large amount of hair grows on the surface of the target region, injection can be performed more easily.

By the way, the above-mentioned 1st protrusion member is good to be a plate-shaped member formed from elastic materials, such as silicon rubber, for example. The dimension and elastic properties of the member can be maintained in a state where the tilted body hair is tilted against its restoring force, and until the injection port protrudes from the tip of the member to the injection direction side. What is necessary is just to set suitably so that it can deform | transform. The elastic property of the member is determined by the direction in which the tip of the first projecting member is moved in order to tilt the hair by deforming the first projecting member when the injection port is brought close to the contact position. May be appropriately set so that the injection port moves in the opposite direction. Note that the width of the member is preferably at least the diameter of the injection port. In addition, the movement along the surface of the injection target region by the tip of the first projecting member described above is caused by movement of the housing of the needleless syringe in the direction along the surface of the injection target region, And movement caused by the deformation of the first projecting member when moved in a direction approaching the injection target region.

  In the needleless syringe described above, the first projecting member may be provided with a comb-like portion at the tip for combing the body hair. According to this configuration, the movement along the injection target region by the tip becomes smoother, so that the hair can be tilted more easily.

  The needleless syringe described above may include an adjustment unit for adjusting the amount of protrusion of the first protrusion member in the injection direction. Here, when the body hair growing in the injection target region is relatively long, it is more possible to bring the tip of the first projecting member into contact with the injection target region or to stably maintain the tilted state of the body hair. It will be difficult. In this case, it is considered that a series of operations for bringing the injection port into contact with each other becomes easier as the protruding amount of the first protruding member increases. Therefore, by adopting such a configuration, it becomes possible to adjust the protruding amount of the first protruding member according to the length of the body hair growing in the injection target region, so that injection can be performed more easily. Is possible.

  In addition to the first projecting member, the needleless syringe according to the present invention is a member provided on the housing, the tip of which projects from the ejection port toward the injection direction of the injection target substance, A second projecting member that exposes the abutment position by tilting the hairs growing on the surface in the moving direction by the movement of the tip along the surface of the injection target region; When the injection port is brought close to the contact position, the inclined body hair is deformed while maintaining the tilted state, so that the injection port is moved to the injection direction side from the tip of the second projecting member. It may be configured to protrude. The first projecting member and the second projecting member are configured such that their tips abut on one side and the other side across the abutting position, and the injection port is in the abutting position. When approaching, it is good to be comprised so that each front-end | tip may move to the opposite direction which leaves | separates from a corresponding contact position.

  According to the above-described configuration, when the injection port is brought close to the contact position, the hair that grows on one side and the hair that grows on the other side sandwich the contact position on the surface of the injection target region. Each of the first projecting member and the second projecting member is tilted in opposite directions away from the contact position. And each of the above-mentioned 1st protrusion member and 2nd protrusion member deform | transforms, maintaining the body hair which each inclined in the inclined state. Therefore, according to the needleless syringe having the above-described configuration, the injection port can be brought into contact with the contact position in a state where the body hairs on both sides of the contact position are tilted. In comparison with the configuration in which only the head is provided, injection can be performed more easily.

  Moreover, in the needleless syringe described above, the second projecting member may include a comb-like portion for combing the body hair at the tip thereof. According to this configuration, the movement along the injection target region by the tip becomes smoother, so that the hair can be tilted more easily.

In the needleless syringe described above, the first projecting member is provided on one side surface of the housing, and is tilted to tilt the hair that grows in the vicinity of the contact position in the moving direction of the tip. The first projecting member of the body hair that is provided on the other side facing the one side surface of the housing and grows in the vicinity of the contact position. The tip may be provided with a tilting portion for tilting other body hair that is not tilted by the tip in the moving direction of the tip. When the first projecting member is provided on one side surface of the housing and the second projecting member is provided on the other side surface facing the side surface, the respective tips of both projecting members are brought into contact with the injection target region. The contact position at that time may be a position that is separated to some extent in the direction along the surface of the injection target region from the position where the injection port is subsequently contacted. That is, in this case, since the tips of both protruding members do not reach the vicinity of the contact position, it is difficult to tilt the hair that grows in the vicinity of the contact position. Therefore, if the above-described configuration is adopted, the hair that grows in the vicinity of the contact position can be tilted by the tilting portion provided at the tip of each of the protruding members, so that the injection port is brought close to the contact position. Sometimes, the contact position can be exposed more reliably.

  The needleless syringe described above may further include a further adjustment unit for adjusting the protruding amount of the second protruding member in the injection direction. With this configuration, as described above, it is possible to adjust the protruding amount of the second protruding member according to the length of the hair that grows in the injection target region, so that injection can be performed more easily. It becomes possible.

  In addition to the first projecting member, the needleless syringe according to the present invention is a member provided at the housing, the tip projecting from the tip of the first projecting member toward the injection direction of the injection target substance. The third hair exposes the contact position where the injection port is contacted by tilting the hair that grows on the surface in the moving direction by the movement of the tip along the surface of the injection target region. The third projecting member is displaced with respect to the housing while maintaining the tilted body hair in a tilted state when the injection port is brought close to the contact position; The ejection port is projected from the distal end of the third projecting member to the ejection direction side, and the first projecting member and the third projecting member have respective distal ends on one side and the other side across the contact position. Configured to abut And, when the exit opening is brought close to the contact position, the tip of the first protruding member may be configured to move in a direction away from the tip of the abutting position and the third protruding member.

  According to the above-described configuration, when the user first brings the needleless syringe close to the injection target area, the tip of the third projecting member comes into contact with the surface of the injection target area. And if the front-end | tip of a 3rd protrusion member moves along the said surface in the state contact | abutted to the surface of an injection object area | region, the body hair pressed by the said front-end | tip during movement will be inclined in the moving direction. Thereby, the contact position where the injection port contacts is exposed. That is, the third protruding member first tilts the hair that grows on the other side across the contact position. When the injection port is brought close to the contact position, the first protruding member tilts the hair that grows on one side across the contact position in a direction away from the contact position. When the injection port is brought close to the contact position, the body hair on which the first projecting member is tilted is deformed while maintaining the tilted state, and the body hair on which the third projecting member is tilted is maintained in the tilted state. Displaces while. Therefore, according to the needleless syringe having the above-described configuration, the injection port can be brought into contact with the contact position in a state where the body hairs on both sides of the contact position are tilted. In comparison with the configuration in which only the head is provided, injection can be performed more easily.

  According to the needleless syringe according to the present invention, it is possible to perform injection more easily into an injection target region in which a relatively large amount of hair is growing on the surface.

It is sectional drawing which shows schematic structure of the syringe which concerns on a 1st Example. It is a perspective view which shows schematic structure of the injection device which concerns on a 1st Example. It is sectional drawing which shows schematic structure of the igniter (ignition apparatus) with which the injection device which concerns on a 1st Example is mounted | worn. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 1st Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 1st Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 1st Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 2nd Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 2nd Example. It is a front view which shows schematic structure of the syringe which concerns on a 2nd Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 3rd Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 3rd Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 4th Example. It is a figure which shows the execution procedure at the time of injecting into the injection object area | region using the syringe which concerns on a 4th Example.

  Embodiments of a needleless syringe according to the present invention will be described below with reference to the drawings. In addition, the structure of the following example is an illustration and this invention is not limited to the structure of this embodiment.

[Example 1]
FIG. 1 is a cross-sectional view schematically showing the configuration of a syringe 1 according to the first embodiment of the present invention. FIG. 2 is a perspective view of the syringe 1 as viewed from the distal end side. The syringe 1 is a needleless syringe that does not have an injection needle that directly delivers an injection solution corresponding to an injection target substance according to the present invention to an injection target region (for example, an animal skin structure) in a living body. In this embodiment, the injection target substance is liquid, but this is not intended to limit the content or form of the substance injected into the living body. As described above, for example, substances to be injected into the skin structure vary depending on the purpose of the treatment. Therefore, as long as the component to be delivered to the skin structure is adapted to the purpose of the treatment, it may be dissolved. As long as it does not have to be dissolved and the injection target substance can be ejected from the syringe 1 to the skin structure by energy, its specific form is not limited, and various forms such as liquid and gel are available. The form can be adopted.

  The syringe 1 includes a housing 2 that forms an outer shell container, in which a nozzle holder 5, a piston holder 3, and an igniter holder 12 are arranged in a line from the front end portion to the rear end portion. As shown in FIG. 2, the housing 2 has a substantially rectangular parallelepiped shape, but the shape of the housing itself is not limited in the present invention. Moreover, the nozzle holder 5, the piston holder 3, and the igniter holder 12 have a substantially cylindrical shape. The nozzle 30, the piston holder 3, and the igniter holder 12 are fixed in the housing 2 by attaching the cap 30 from the rear end portion of the housing 2. In the present embodiment, the term “tip portion” means the end portion of the component in the injection direction of the injection solution (the propulsion direction of the piston 4) as will be described later. Reference to “end” means the end of the component on the side opposite the tip.

  Here, an inner hole 2 a that defines a space for accommodating the nozzle holder 5, the piston holder 3, and the igniter holder 12 is formed in the housing 2. Furthermore, a through-hole 2b is provided at the tip of the housing 2 so as to communicate the inner hole 2a with the outside of the housing 2. The centers of the through hole 2b and the inner hole 2a are provided coaxially, and the inner diameter of the through hole 2b is set smaller than the inner diameter of the inner hole 2a. Therefore, a step portion 2 c is formed inside the front end portion side of the housing 2.

  Here, the example of the igniter 20 attached to the igniter holder 12 is demonstrated based on FIG. The igniter 20 is an electric igniter, and a space for arranging the igniting agent 22 is defined in the cup 21 by a cup 21 whose surface is covered with an insulating cover. And the metal header 24 is arrange | positioned in the space, and the cylindrical charge holder 23 is provided in the upper surface. The charge holder 23 holds the ignition agent 22. A bridge wire 26 that electrically connects one conductive pin 28 and the metal header 24 is wired at the bottom of the ignition agent 22. The two conductive pins 28 are fixed to the metal header 24 via the insulator 25 so that they are insulated from each other. Furthermore, the opening side of the cup 21 from which the two conductive pins 28 extend is protected by the resin 27 in a state in which the insulation between the conductive pins 28 is well maintained.

  In the igniter 20 configured as described above, when a voltage is applied between the two conductive pins 28 by a power source unit (not shown) connected to the cap 30, a current flows through the bridge wire 26, thereby causing the ignition charge. 22 burns. This voltage application is realized by the user pressing a button on the power supply unit. As a result of the voltage application, the combustion products resulting from the combustion of the igniting agent 22 are ejected from the opening of the charge holder 23. Therefore, in the present invention, the relative product of the igniter 20 with respect to the igniter holder 12 is such that the combustion product of the igniter 22 in the igniter 20 flows into the combustion chamber 11 formed inside the igniter holder 12. The positional relationship is set.

  The igniting agent 22 used in the syringe 1 is preferably an explosive containing zirconium and potassium perchlorate (ZPP), an explosive containing titanium hydride and potassium perchlorate (THPP), titanium and potassium perchlorate. Gunpowder containing (TiPP), Gunpowder containing aluminum and potassium perchlorate (APP), Gunpowder containing aluminum and bismuth oxide (ABO), Gunpowder containing aluminum and molybdenum oxide (AMO), Gunpowder containing aluminum and copper oxide (ACO) ), Explosives containing aluminum and iron oxide (AFO), or explosives composed of a combination of these explosives. These explosives generate high-temperature and high-pressure plasma at the time of combustion immediately after ignition. However, when the combustion product is condensed at a normal temperature and does not contain a gas component, the generated pressure rapidly decreases. In addition, you may use explosives other than these as an ignition powder.

  Here, nothing is arranged in the combustion chamber 11 shown in FIG. 1, but a known gas generating agent that generates gas by burning with combustion products generated by the combustion of the igniting agent 22 is contained in the combustion chamber 11. It may be arranged. Assuming that a gas generating agent is disposed in the combustion chamber 11, a single base smokeless explosive composed of 98% by mass of nitrocellulose, 0.8% by mass of diphenylamine, and 1.2% by mass of potassium sulfate is exemplified. It is also possible to use various gas generating agents that are used in gas generators for airbags and gas generators for seat belt pretensioners. The combined use of such a gas generating agent is different from the case of only the igniting agent 22 described above, and the predetermined gas generated at the time of combustion contains a gas component even at room temperature, so the rate of decrease in generated pressure is small. Furthermore, although the combustion completion time at the time of combustion of the gas generating agent is extremely long as compared with the igniting agent 22, the size, size and shape of the gas generating agent when disposed in the combustion chamber 11, especially the surface By adjusting the shape, it is possible to change the combustion completion time of the gas generating agent. Thus, by adjusting the amount, shape, and arrangement of the gas generating agent, the generated pressure in the combustion chamber 11 can be adjusted as appropriate.

Next, a through hole 31 for holding the metal piston 4 is formed in the metal piston holder 3 before using the syringe 1 shown in FIG. The piston 4 is disposed so as to be slidable in the through hole 31 along the axial direction, and one end (rear end side) thereof is exposed to the combustion chamber 11 side, and the other end (front end side). ) Is integrally attached with a sealing member 4a. The sealing member 4a is made of rubber having a surface coated with a thin silicone oil so that the injection solution can smoothly move in the through hole 14 as the piston 4 slides. In order to reduce friction between the piston 4 or the sealing member 4a and the through hole 31 in the piston holder 3, for example, a sealing member made of fluoro rubber can be used. Further, silicon treatment can be performed on the surface of the through hole 31.

  Furthermore, a nozzle holder 5 that holds a nozzle portion 6 for injecting an injection solution is disposed adjacent to the piston holder 3 on the distal end side of the syringe 1. The nozzle portion 6 has a substantially cylindrical shape. The nozzle holder 5 is formed with an inner hole 5a that defines a space for accommodating the nozzle portion 6, and the inner hole 5a is exposed to the outside at the distal end side of the inner hole 5a. The tapered portion 5b is formed in accordance with the surface shape of the nozzle portion 6 so as to be held in the state.

  On the other hand, the nozzle portion 6 has an outer diameter that substantially matches the inner diameter of the inner hole 5 a of the nozzle holder 5, and a tapered portion corresponding to the tapered portion 5 b of the nozzle holder 5 is formed on the tip end side. . The nozzle portion 6 is formed with a flow path 6a through which an injection solution finally injected from the syringe 1 flows and an injection port 6b through which the injection solution is injected. The tip portion of the nozzle portion 6 is formed so as to protrude to the injection direction side from the tip surface 2 d of the housing 2 and the tip surface 5 c of the nozzle holder 5. Thereby, when the injection port 6b is brought into contact with the injection target region, the injection port 6b can be more closely attached to the injection target region.

  The nozzle portion 6 can be mass-produced by resin molding, and is formed so that it can be replaced with a new nozzle portion every time an injection solution is injected. As a result, the user of the syringe 1 can always use the new nozzle unit 6 every time the injection solution is injected, and a hygienic injection is realized. The shape, size, and the like of the flow path 6a are factors that determine the behavior of the injection solution injected from the syringe 1 after injection. Therefore, by forming the nozzle part 6 to be exchangeable as described above, it is possible to select the nozzle part 6 having a flow path suitable for feeding the injection solution to be injected into the target in-vivo region. The injection of the injection solution can be suitably realized.

  As described above, when the nozzle portion 6 and the nozzle holder 5, the piston 4 and the piston holder 3, and the igniter holder 12 are arranged in the housing 2, in the state before the use of the syringe 1 shown in FIG. An accommodation space 13 capable of accommodating an injection solution is formed between the sealing member 4a attached to the nozzle portion 6 and the recess 6c of the nozzle portion 6. In the syringe 1 of FIG. 1, the injection solution is loaded into the storage space 13 after the syringe 1 is assembled. In the configuration shown in FIG. 1, the injection solution is not enclosed in a completely closed space, and the distal end side of the syringe is open. However, since the inner diameter of the injection port 6b of the nozzle portion 6 is extremely small (for example, 100 μm), the surface tension of the injection solution is maintained even if the accommodation space 13 is a semi-closed space as long as no load is applied by the piston 4 as described above. Thus, the injection solution can be held in the storage space 13. As will be described later, the loaded injection solution is injected from the injection port 6 b of the nozzle unit 6 by being pressurized with energy generated by the combustion of the igniting agent 22 in the igniter 20.

In the syringe 1 configured as described above, when the power supply unit is connected to the igniter 20 in a state where the injection port 6b is in close contact with the injection target region, the igniter 20 is activated by the current from the power supply unit. . Then, combustion products are filled in the combustion chamber 11 by the combustion of the igniting agent 22, and the pressure is transmitted to the piston 4 as energy for injection of the injection solution. In response to the energy, the piston 4 propels the through hole 31 and applies pressure to the injection solution stored in the storage space 13, so that the injection target is injected from the injection port 6 b through the flow path 6 a of the nozzle portion 6. The injection solution is ejected toward the area. Since pressure is applied to the injected injection solution, the injection solution penetrates the surface of the injection target region and reaches the inside thereof, thereby achieving the purpose of injection in the syringe 1. In the contact portion between the piston holder 3 and the nozzle portion 6,
Known sealing means can be provided.

  By the way, in the syringe 1, the side surface 2e of the housing 2 is provided with a protruding member 8 for tilting the body hair growing on the skin as the surface of the injection target region. The projecting member 8 is formed of a plate-like elastic body having a width substantially the same as the width of the side surface 2e of the housing 2 (see FIG. 2), and its tip 8a is from an injection port 6b provided in the nozzle portion 6. It is provided so as to protrude to the injection direction side of the injection solution. Although the degree of elasticity of the protruding member 8 will be described later, an example of the elastic body is silicon rubber. In addition, the tip 8a is formed in a tapered shape so that the movement along the injection target region becomes smoother, and a comb-like portion 8b in which comb teeth for combing hair in the width direction are formed. Prepare. Further, the protruding member 8 is positioned with respect to the side surface 2 e of the housing 2 by fixing the rear end portion thereof by the adjusting portion 9. The adjusting portion 9 has a fixing screw 9a for fixing the protruding member 8, and the protruding member 8 can be fixed to the side surface 2e by tightening the fixing screw 9a. By adopting such an adjusting portion 9, the projecting member 8 is slid in the longitudinal direction of the housing 2 after loosening the fixing screw 9a, whereby the projecting amount P of the projecting member 8 from the front end surface 2d of the housing 2 is obtained. Can be adjusted appropriately.

  Here, the execution procedure at the time of injecting into the injection object area | region where the body hair grows using the syringe 1 is demonstrated using FIG. 4A to 4C. 4A to 4C are diagrams schematically showing a state in which the distal end portion of the syringe 1 is viewed from the side, and illustrations of unnecessary structures are appropriately omitted for explanation of the execution procedure.

  First, when the syringe 1 is brought closer to the skin S on which the body hair H grows by a user operation, the tip 8a of the protruding member 8 comes into contact with the skin S as shown in FIG. 4A. Part or all of the tip 8a may be in contact with the skin S with the body hair H interposed therebetween, but in order to suppress the body hair H from being sandwiched between the tip 8a and the skin S as much as possible. In addition, it is desirable to bring the protruding member 8 close to the skin S so as to substantially follow the angle of the body hair H.

  Next, when the syringe 1 is moved in the direction along the skin S in a state where the tip 8a of the protruding member 8 is in contact with the skin S, the tip 8a is pressed during the movement as shown in FIG. 4B. A part of the hair H is tilted in the moving direction of the tip 8a. As a result, the contact position R1 at which the injection port 6b can be brought into contact with the vicinity of the root of the tilted body hair H is exposed to the extent that the user can see it. Here, since the comb-like part 8b for combing the hair H is provided at the tip 8a, the tip 8a moves smoothly. The angle of the body hair H that is tilted depends on the length and amount of the body hair H, and further, the pressing force by the protruding member 8. Therefore, the user may adjust the pressing force for pressing the hair H through the moving distance D of the tip 8a and the protruding member 8 so that the contact position R1 is sufficiently exposed.

Here, the dimensions and elastic properties of the projecting member 8 are such that when the ejection port 6b is brought close to the contact position R1, the ejection port 6b is deformed while maintaining the tilted body hair H in a tilted state. It is set so that it can protrude from the tip 8a toward the injection direction. Specifically, when a force is applied by the user to bring the injection port 6b closer to the contact position R1, the protruding member 8 is deformed so as to be bent with the tip 8a as a fulcrum. Thereby, since the tilted state of the hair H held by the tip 8a is maintained, the state where the contact position R1 is exposed can be maintained. Further, since the protruding member 8 is deformed in this way, the injection port 6b can be moved to some extent in the direction opposite to the direction in which the body hair H tilts when the injection port 6b is brought close to the contact position R1. Become. In the state shown in FIG. 4B, the tip 8a of the protruding member 8 is separated from the skin S by the thickness of the body hair H sandwiched between itself and the skin S. The elastic property of the member 8 is set so that the injection port 6b can protrude from the tip 8a toward the injection direction. Therefore, the protruding member 8 can be deformed until the injection port 6b comes into contact with the contact position R1, as shown in FIG. 4C. Therefore, the user can bring the injection port 6b into contact with the contact position R1 while avoiding the body hair H by performing an operation of bringing the injection port 6b close to the exposed contact position R1.

  4A, when the hair H is relatively long, when the tip 8a of the projecting member 8 is first brought into contact with the skin S, the ejection port 6b interferes with the hair H. It is easy to receive. In this case, the operation of abutting the tip 8a becomes easier when the protruding amount P of the protruding member 8 from the tip surface 2d of the housing 2 is larger. As assumed from FIG. 4C, when the deformed projecting member 8 maintains the contact position R <b> 1 until the injection port 6 b contacts the contact position R <b> 1, the curved projecting member The body hair H is also pressed by the 8 torso parts 8b. Therefore, it can be said that the larger the protrusion amount P, the easier it is to maintain the tilted state of the body hair H. Therefore, by appropriately adjusting the protruding amount P of the protruding member 8 using the adjusting unit 9 according to the length of the body hair H, the operation of bringing the injection port 6b into contact with the contact position R1 while avoiding the body hair H is performed. It becomes easier.

  As described above, according to the syringe 1 according to the present embodiment, the injection port can be avoided while avoiding the body hair H only by the operation of bringing the syringe 1 close to the skin S without performing treatment for removing the body hair H in advance. 6b can be brought into contact with the skin S. As a result, even if the skin has a relatively large amount of hair, injection can be performed more easily and reliably without leaking the injection solution.

[Example 2]
Next, a syringe 101 according to a second embodiment of the present invention will be described based on FIGS. 5A, 5B and 6. FIG. 5A and 5B are views schematically showing a state in which the distal end portion of the syringe 101 is viewed from the side, similarly to FIG. 4A and the like, and the execution procedure when injecting into the skin S using the syringe 101 is shown. It is a figure for demonstrating. FIG. 6 is a front view of the syringe 101 as viewed from the distal end side. In the following description, among the constituent elements of the syringe 101, those substantially the same as the constituent elements of the above-described syringe 1 will be denoted by the same reference numerals and description thereof will be omitted as appropriate.

  A syringe 101, which is a needleless syringe, has a housing 102 whose internal structure is substantially the same as that of the syringe 1 described above. Therefore, as shown in FIG. 5A, the injection port 6 b of the nozzle portion 6 protrudes more toward the injection direction than the front end surface 102 d of the housing 102, and the igniter 20 with the injection port 6 b in close contact with the skin S. When the power supply unit is connected to (not shown), the injection solution is ejected toward the skin S from the ejection port 6b.

Here, in the syringe 101, a first projecting member 108 and a second projecting member 109 are provided in order to tilt the hair H growing on the skin S. The first projecting member 108 is formed of an elastic body having the same elastic properties as the projecting member 8 in the first embodiment described above. As shown in FIG. Provided on opposite side surfaces. Moreover, the 2nd protrusion member 109 also has the same structure. As shown in FIG. 5A, the first projecting member 108 and the second projecting member 109 are provided such that the respective tips 108a and 109a project from the ejection port 6b to the ejection direction side. Each of the projecting members 108 and 109 is provided on both sides of the housing 102 with the injection port 6b interposed therebetween. Both protruding members 108 and 109 have a shape bent so as to intersect each other when the syringe 101 is viewed from the side as shown in FIG. 5A. Since both the projecting members 108 and 109 have such a shape, the respective distal ends 108a and 109a are positioned on one side and the other side across the injection port 6b. By configuring the projecting members 108 and 109 in this way, when the housing 102 is pressed against the skin S, the contact position R2 is brought close to the contact position R2 where the injection port 6b comes into contact. The front ends 108a and 109b abut on one side and the other side across R2, and the front ends 108a and 109a move in opposite directions away from the abutment position R2 in the horizontal direction along the skin S. . Further, like the distal end 8a of the protruding member 8 in the syringe 1 described above, the distal end 108a is formed in a tapered shape as shown in FIG. 6, and a comb-like portion for combing hairs in the width direction is formed. 108b. Similarly, the tip 109a includes a comb-like portion 109b. With such a configuration, the movement along the skin S by the tips 108a and 109a becomes smoother. Further, similarly to the above-described syringe 1, the first projecting member 108 includes an adjusting unit 110 for adjusting the projecting amount from the distal end surface 102 d of the housing 102. Moreover, the 2nd protrusion member 109 is similarly provided with the adjustment part 111. FIG. With such a configuration, similarly to the above-described syringe 1, the protruding amounts of both the protruding members 108 and 109 can be adjusted as appropriate, so that the operation of bringing the injection port 6b into contact with the contact position R1 is easier. become.

  Hereafter, the execution procedure at the time of injecting into the skin S where the hair H grows using the syringe 101 is demonstrated using FIG. 5A and 5B. First, when the syringe 101 is moved closer to the skin S by the user's operation, the distal end 108a of the first projecting member 108 and the distal end 109a of the second projecting member 109 are in contact with the skin S as shown in FIG. 5A. Abut.

  Next, when the injection port 6b is brought almost perpendicular to the skin S in a state where both the tips 108a and 109a are in contact with the skin S, both the protruding members 108 and 109 are deformed so as to be curved. The respective leading ends 108a and 109a move in opposite directions away from the contact position R2. As a result, the hair H on one side and the hair H on the other side are tilted in opposite directions across the contact position R2, so that the contact position R2 is exposed near the root of the tilted body hair H. . Both projecting members 108 and 109 can be deformed while maintaining the state in which the hair H is tilted until the injection port 6b contacts the contact position R2. Therefore, when the user brings the injection port 6b closer to the skin S in a substantially vertical direction, the injection port 6b can be easily brought into contact with the contact position R2, as shown in FIG. 5B.

  As described above, according to the syringe 101 according to the present embodiment, since the two protruding members are provided, only the operation of bringing the injection port 6b close to the skin S in the vertical direction is performed, and the body hair H is avoided. The injection port 6b can be brought into contact with the skin S. Therefore, according to the present embodiment, it becomes possible to perform injection even more easily.

[Example 3]
Next, a syringe 201 according to a third embodiment of the present invention will be described based on FIGS. 7A and 7B. 7A and 7B are diagrams schematically showing a state in which the distal end portion of the syringe 201 is viewed from the side, like FIG. 4A and the like, and an execution procedure when performing injection into the injection target region using the syringe 201 It is a figure for demonstrating. In the following description, among the components of the syringe 201, the components that are substantially the same as the components of the syringe 1 described above will be denoted by the same reference numerals and the description thereof will be omitted as appropriate.

  A syringe 201 which is a needleless syringe has a housing 202 having an internal structure substantially the same as that of the above-described syringe 1. Therefore, as shown in FIG. 7A, the injection port 6 b of the nozzle portion 6 protrudes more toward the injection direction than the front end surface 202 d of the housing 202, and the igniter 20 is in a state where the injection port 6 b is in close contact with the skin S. When the power supply unit is connected to (not shown), the injection solution is ejected toward the skin S from the ejection port 6b.

Here, the syringe 201 is provided with a first projecting member 208 and a second projecting member 209 in order to tilt the hair H growing on the skin S. Both projecting members 208 and 209 are formed of a plate-like elastic body having the same elastic properties as the projecting member 8 in the first embodiment. As shown in FIG. 7A, the first projecting member 208 is provided on one side surface 202a of the housing 202, and the tip 208a tilts the hair that grows in the vicinity of a contact position R3 described later. The tilt part 218 is provided. The inclined portion 218 has a plurality of thin bristles 218a provided in the width direction of the tip 208a and projecting toward the injection port 6b. A spherical tip 218b is formed at the tip of each brush bristles 218a. Yes. The brush bristles 218a are formed from a material having appropriate flexibility for combing the body hair H. The tip 218b softens the stimulation on the skin S and allows the hair H to be tilted more effectively by the brush bristles 218a. In addition, among the plurality of brush bristles 218a, the one that protrudes most from the tip 208a of the protruding member 208 toward the injection port 6b protrudes directly below the injection port 6b. Specifically, as shown in FIG. 7A, when the injection port 6b is provided at the center of the housing 202, the protruding amount L of the brush bristles 218a that protrudes most to the injection port 6b side is the width of the housing. It becomes half the value of W. In addition, the second projecting member 209 having the same configuration as the first projecting member 208 is provided on the other side surface 202b of the housing 202, and a body hair that grows in the vicinity of the contact position R3 at the tip 209a. Is provided with a tilting part 219 for tilting. In addition, the tilt part 219 has a plurality of brush bristles 219a formed with a spherical tip 219b, like the tilt part 218 described above. The number, length, etc. of the brush bristles 219a are the same as those of the above-described brush bristles 218a.

  Similarly to the above-described syringe 2, the first projecting member 208 includes an adjustment unit 210 for adjusting the amount of projection from the distal end surface 202 d of the housing 202. Moreover, the 2nd protrusion member 209 is also provided with the adjustment part 211 similarly. With such a configuration, similarly to the above-described syringe 2, the protruding amounts of both the protruding members 208 and 209 can be adjusted as appropriate, so that the operation of bringing the injection port 6b into contact with the contact position R3 is easier. become.

  Hereafter, the execution procedure at the time of injecting into the skin S where the hair H grows using the syringe 201 is demonstrated using FIG. 7A and 7B. First, when the syringe 201 is moved closer to the skin S by the user's operation, the tips 218b and 219b come into contact with the skin S as shown in FIG.

  Next, when both the front ends 218b and 219b are in contact with the skin S and the injection port 6b is brought almost perpendicular to the skin S, both the protruding members 208 and 209 are deformed so as to bend. The respective leading ends 208a and 209a move in opposite directions away from the contact position R3. When both the tips 108a and 109a move, the one side hair H and the other side hair H sandwich the contact position R3 by the inclined portions 218 and 219 that move in opposite directions away from the contact position R3. Tilt in opposite directions. Thereby, the contact position R3 with which the injection port 6b is contacted is exposed. Both projecting members 208 and 209 can be deformed while maintaining the state in which the hair H is tilted until the injection port 6b contacts the contact position R3. Therefore, when the user brings the ejection port 6b closer to the skin S in a substantially vertical direction, the ejection port 6b can be easily brought into contact with the contact position R3 as shown in FIG. 7B.

As described above, according to the syringe 201 according to the present embodiment, the body hair H that grows in the vicinity of the contact position R3 can be tilted by the tilting portions 218 and 219 provided in the projecting members 208 and 209, respectively. Therefore, the injection port 6b can be brought into contact with the skin S while avoiding the body hair H only by performing an operation of bringing the injection port 6b close to the skin S in the vertical direction. Therefore, according to the present embodiment, it becomes possible to perform injection even more easily. Both projecting members 208 and 209 are inclined in advance with respect to the housing 202 (that is, the distance between the projecting members 208 and 209 is such that the tips 208a and 209a are deformed as shown in FIG. 7B). It may be attached in such a state that the tip 208a, 209a becomes larger. In this case, the first protruding member 208 among the plurality of brush bristles 218a.
The amount of protrusion that protrudes most from the tip 208a toward the injection port 6b is set so that the tip 218b protrudes directly below the injection port 6b (the same applies to the brush bristles 219a). Further, the brush hairs 218a and 219a are attached for the purpose of tilting the body hair H and maintaining the state thereof, and in order to achieve this purpose, the direction in which the brush hairs extend before use is not limited.

[Example 4]
Next, a syringe 301 according to a fourth embodiment of the present invention will be described with reference to FIGS. 8A and 8B. 8A and 8B are diagrams schematically showing a state in which the distal end portion of the syringe 301 is viewed from the side, similarly to FIG. 4A and the like, and an execution procedure when injecting into the skin S using the syringe 301 is shown. It is a figure for demonstrating. In the following description, among the components of the syringe 301, the components that are substantially the same as the components of the syringe 1 described above are denoted by the same reference numerals and description thereof is omitted as appropriate.

  A syringe 301, which is a needleless syringe, has a housing 302 whose internal structure is substantially the same as that of the syringe 1 described above. Therefore, as shown in FIG. 8A, the injection port 6 b of the nozzle portion 6 protrudes toward the injection direction from the front end surface 302 d of the housing 302, and the igniter 20 is in a state where the injection port 6 b is in close contact with the skin S. When the power supply unit is connected to (not shown), the injection solution is ejected toward the skin S from the ejection port 6b.

  Here, in the syringe 301, a first projecting member 308 and a second projecting member 309 are provided in order to tilt the hair H growing on the skin S. As shown in FIG. 8A, the tip 309a of the second projecting member 309 projects from the tip 308a of the first projecting member 308 toward the injection direction of the injection solution. Further, each of the first projecting member 308 and the second projecting member 309 is provided on both sides of the injection opening 6b in the housing 302 in the same manner as in the above-described second embodiment, and as shown in FIG. When viewed from the side, it has a bent shape so as to cross each other. Therefore, the tips 308a and 309a are located on one side and the other side across the injection port 6b. Further, the front view of the syringe 301 viewed from the distal end side is the same as that shown in FIG. Here, the first projecting member 308 has the same elastic properties and shape as the first projecting member 108 in Example 2 described above. On the other hand, the second projecting member 309 has the same shape as the second projecting member 109 in the second embodiment described above, but is formed of a rigid body and is slidable in the injection direction of the injection solution with respect to the housing 302. Is provided. Specifically, the fixed end of the second projecting member 309 is slidably fixed to a slide rail 310 extending in the longitudinal direction provided on the opposite side surface of the housing 302. By configuring the projecting members 308 and 309 in this way, the tip 308a moves away from the contact position R4 in the horizontal direction along the skin S when the injection port 6b is brought close to the contact position R4 described later. The tip 309a is displaced in the direction opposite to the injection direction described above with respect to the housing 302.

  As in the second embodiment, comb-shaped portions for combing hair may be provided at the tips 308a and 309b of the projecting members 308 and 309, respectively. Moreover, you may provide the adjustment part for adjusting the protrusion amount from the front end surface 302d of the housing 302 of both the protrusion members 308 and 309. FIG.

  Hereafter, the execution procedure at the time of injecting into the skin S where the hair H grows using the syringe 301 is demonstrated using FIG. 8A and 8B. First, when the syringe 301 is moved closer to the skin S by the user's operation, the tip 309 a of the second projecting member 309 comes into contact with the skin S. Next, when the syringe 301 is moved in the direction along the skin S (the direction of the arrow shown in FIG. 8A) with the tip 309a in contact with the skin S, as shown in FIG. A part of the hair H pressed by 309a is tilted in the moving direction of the tip 309a.

  Next, in a state where a part of the hair H is tilted by the tip 309a, when the injection port 6b is brought almost perpendicular to the skin S, the first projecting member 308 is deformed so as to be curved, The tip 308a moves in a direction away from the contact position R4 and the tip 309a of the second projecting member 309. Thereby, a part of the non-tilted body hair H in the vicinity of the contact position R4 is tilted in the moving direction of the tip 308a. Thereby, the contact position R4 with which the injection port 6b is contacted is exposed. The first projecting member 308 can be deformed while maintaining the state where the body hair H is tilted until the injection port 6b contacts the contact position R4. On the other hand, the second projecting member 309 can be displaced with respect to the housing 302 while maintaining the state where the hair H is tilted until the injection port 6b contacts the contact position R4. Therefore, when the user brings the ejection port 6b closer to the skin S in a substantially vertical direction, the ejection port 6b can be easily brought into contact with the contact position R4 as shown in FIG. 8B.

  As described above, according to the syringe 301 according to the present embodiment, the body hair H growing in the vicinity of the contact position R4 can be tilted by each of the projecting members 308 and 309. It is possible to bring the injection port 6b into contact with the skin S while avoiding the body hair H by performing an operation of approaching S in the vertical direction. Therefore, according to the present embodiment, injection can be performed more easily.

  In the present embodiment, a switch 311 for connecting the power supply unit to the igniter 20 may be provided on the slide rail 310. Since the 2nd protrusion member 309 is comprised from the rigid body, based on the position of the 2nd protrusion member 309 on the slide rail 310, the position of the front-end | tip 309a of the 2nd protrusion member 309 is detectable. Therefore, when it is detected that the tip 309a has reached a position protruding from the injection port 6b toward the injection direction of the injection solution, the switch 311 for connecting the power supply unit is closed so that the injection port 6b is connected to the skin. It is possible to provide a needleless syringe in which an injection solution is automatically ejected when it abuts against S.

  In the above embodiments, the shape of the housing is a substantially rectangular parallelepiped, but the cross-sectional shape of the housing may be other shapes such as a circle and an ellipse as long as the projecting member can be arranged so as to exhibit the above mechanism via an adapter. . The drive source uses explosives, but it may be a pressurized gas or a spring.

DESCRIPTION OF SYMBOLS 1, 101, 201, 301 ...... Syringe 2, 102, 202, 302 ...... Housing 6 ...... Nozzle part 6b ...... Injection port 8 ...... Projection member 108, 208, 308 .... First projecting member 109, 209, 309 ... Second projecting member R1, R2, R3, R4 ... Contact position

Claims (8)

A needleless syringe that injects the injection target substance into the injection target region of a living body having body hair by ejecting the injection target substance without going through an injection needle,
A housing forming an outer shell container of the needleless syringe;
A nozzle part provided in the housing and formed with an injection port through which the injection target substance is injected;
Provided in the housing is a member whose tip protrudes from the injection port toward the injection direction of the injection target substance, and grows on the surface by movement along the surface of the injection target region by the tip. A first projecting member that exposes a contact position where the injection port is contacted by tilting body hair in the moving direction;
The first projecting member is deformed while maintaining the tilted body hair in a tilted state when the ejection port is brought close to the contact position, so that the ejection port becomes a tip of the first projecting member. A needleless syringe that protrudes more toward the injection direction. The first projecting member includes a first comb-shaped portion for combing the body hair at a tip thereof.
The needleless syringe according to claim 1. A first adjusting unit for adjusting a protruding amount of the first protruding member in the injection direction;
The needleless syringe according to claim 1 or 2. Provided in the housing is a member whose tip protrudes from the injection port toward the injection direction of the injection target substance, and grows on the surface by movement along the surface of the injection target region by the tip. A second projecting member that exposes the contact position by tilting the hair in the direction of movement;
The second projecting member deforms the tilted body hair while maintaining the tilted body hair in a tilted state when the ejection port is brought close to the contact position, so that the tip of the second projecting member is deformed. More protruding in the injection direction side,
The first projecting member and the second projecting member are configured such that respective leading ends abut on one side and the other side across the abutting position, and the injection port approaches the abutting position. Each tip is configured to move in opposite directions away from the corresponding contact position when
The needleless syringe according to any one of claims 1 to 3. The second projecting member includes a second comb-shaped portion for combing the body hair at a tip thereof.
The needleless syringe according to claim 4. The first projecting member is provided on one side surface of the housing, and includes a first tilting portion at the tip for tilting body hair growing in the vicinity of the contact position in the moving direction of the tip.
The second projecting member is provided on the other side surface of the housing that faces the one side surface, and other body hairs that are not tilted by the first projecting member among the body hairs that grow in the vicinity of the contact position. The tip is provided with a second tilting portion for tilting in the moving direction of the tip.
The needleless syringe according to claim 4. A second adjustment unit for adjusting a protruding amount of the second protruding member in the injection direction;
The needleless syringe according to any one of claims 4 to 6. A member provided on the housing, the tip of which protrudes toward the injection direction of the injection target substance from the tip of the first projecting member, and is moved by the tip along the surface of the injection target region. A third projecting member that exposes a contact position where the injection port is contacted by tilting the hair that grows in the moving direction;
The third projecting member displaces the injection port with respect to the housing while maintaining the inclined body hair in a tilted state when the injection port is brought close to the contact position. 3 project from the tip of the projecting member toward the injection direction,
The first projecting member and the third projecting member are configured such that respective leading ends abut on one side and the other side across the abutting position, and the injection port approaches the abutting position. When configured, the tip of the first projecting member is configured to move in a direction away from the corresponding contact position and the tip of the third projecting member.
The needleless syringe according to any one of claims 1 to 3.

Images